Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly.
Karampitsakos T, Diep PP, Loth DW, Nadeem I, Khurtsidze E, Wijsenbeek MS, Wuyts WA, Bargagli E, Froidure A, Spagnolo P, Veltkamp M, Molina-Molina M, McCarthy C, Antoniou KM, Kreuter M, Moor CC. Karampitsakos T, et al. ERJ Open Res. 2023 Apr 17;9(2):00584-2022. doi: 10.1183/23120541.00584-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37077550 Free PMC article.
Editorial: Immune-mediated lung injury.
Karampitsakos T, Spagnolo P, Tzouvelekis A. Karampitsakos T, et al. Front Med (Lausanne). 2023 Nov 3;10:1292074. doi: 10.3389/fmed.2023.1292074. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38020172 Free PMC article. No abstract available.
Toll-like receptors in the pathogenesis of pulmonary fibrosis.
Karampitsakos T, Woolard T, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Eur J Pharmacol. 2017 Aug 5;808:35-43. doi: 10.1016/j.ejphar.2016.06.045. Epub 2016 Jun 27. Eur J Pharmacol. 2017. PMID: 27364757 Review.
Lung cancer in patients with idiopathic pulmonary fibrosis.
Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Pulm Pharmacol Ther. 2017. PMID: 28377145 Review.
Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.
Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D. Tzouvelekis A, et al. Among authors: karampitsakos t. Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29238708 Free PMC article.
Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.
Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D. Tzouvelekis A, et al. Among authors: karampitsakos t. Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31. Pulm Pharmacol Ther. 2018. PMID: 29366978
118 results